224 related articles for article (PubMed ID: 29307578)
1. Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation.
Li X; Wilson AF; Du W; Pang Q
Stem Cell Reports; 2018 Feb; 10(2):339-346. PubMed ID: 29307578
[TBL] [Abstract][Full Text] [Related]
2. p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells.
Li X; Wu L; Zopp M; Kopelov S; Du W
Stem Cells; 2019 Jul; 37(7):937-947. PubMed ID: 30977208
[TBL] [Abstract][Full Text] [Related]
3. The non-homologous end-joining activity is required for Fanconi anemia fetal HSC maintenance.
Nie Y; Li Y; Li X; Wilson AF; Pang Q
Stem Cell Res Ther; 2019 Mar; 10(1):114. PubMed ID: 30925933
[TBL] [Abstract][Full Text] [Related]
4. Numbers of long-term hematopoietic stem cells from bone marrow of fanca and fancc knockout mice can be greatly enhanced by their collection and processing in physioxia conditions.
Broxmeyer HE; Capitano ML; Cooper S; Potchanant ES; Clapp DW
Blood Cells Mol Dis; 2021 Feb; 86():102492. PubMed ID: 32896825
[TBL] [Abstract][Full Text] [Related]
5. An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation.
Marion W; Boettcher S; Ruiz-Torres S; Lummertz da Rocha E; Lundin V; Morris V; Chou S; Zhao AM; Kubaczka C; Aumais O; Zhang Y; Shimamura A; Schlaeger TM; North TE; Ebert BL; Wells SI; Daley GQ; Rowe RG
Blood Adv; 2020 Oct; 4(19):4679-4692. PubMed ID: 33002135
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.
Ceccaldi R; Parmar K; Mouly E; Delord M; Kim JM; Regairaz M; Pla M; Vasquez N; Zhang QS; Pondarre C; Peffault de Latour R; Gluckman E; Cavazzana-Calvo M; Leblanc T; Larghero J; Grompe M; Socié G; D'Andrea AD; Soulier J
Cell Stem Cell; 2012 Jul; 11(1):36-49. PubMed ID: 22683204
[TBL] [Abstract][Full Text] [Related]
7. The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation.
Du W; Amarachintha S; Erden O; Wilson A; Pang Q
Oncotarget; 2016 Sep; 7(37):60005-60020. PubMed ID: 27507053
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence.
Zhang X; Sejas DP; Qiu Y; Williams DA; Pang Q
J Cell Sci; 2007 May; 120(Pt 9):1572-83. PubMed ID: 17405815
[TBL] [Abstract][Full Text] [Related]
9. Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice.
Rani R; Li J; Pang Q
Cancer Res; 2008 Dec; 68(23):9693-702. PubMed ID: 19047147
[TBL] [Abstract][Full Text] [Related]
10. Fanconi Anemia Mesenchymal Stromal Cells-Derived Glycerophospholipids Skew Hematopoietic Stem Cell Differentiation Through Toll-Like Receptor Signaling.
Amarachintha S; Sertorio M; Wilson A; Li X; Pang Q
Stem Cells; 2015 Nov; 33(11):3382-96. PubMed ID: 26212365
[TBL] [Abstract][Full Text] [Related]
11. Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice.
Zhang QS; Watanabe-Smith K; Schubert K; Major A; Sheehan AM; Marquez-Loza L; Newell AE; Benedetti E; Joseph E; Olson S; Grompe M
Stem Cell Res; 2013 Sep; 11(2):687-92. PubMed ID: 23721813
[TBL] [Abstract][Full Text] [Related]
12. SCO2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem Cells.
Du W; Amarachintha S; Wilson AF; Pang Q
Stem Cells; 2016 Apr; 34(4):960-71. PubMed ID: 26676373
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic gene editing in CD34
Diez B; Genovese P; Roman-Rodriguez FJ; Alvarez L; Schiroli G; Ugalde L; Rodriguez-Perales S; Sevilla J; Diaz de Heredia C; Holmes MC; Lombardo A; Naldini L; Bueren JA; Rio P
EMBO Mol Med; 2017 Nov; 9(11):1574-1588. PubMed ID: 28899930
[TBL] [Abstract][Full Text] [Related]
14. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
[TBL] [Abstract][Full Text] [Related]
15. Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.
Müller LU; Milsom MD; Kim MO; Schambach A; Schuesler T; Williams DA
Mol Ther; 2008 Jun; 16(6):1154-60. PubMed ID: 18398427
[TBL] [Abstract][Full Text] [Related]
16. Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses.
Haworth KG; Ironside C; Ramirez MA; Weitz S; Beard BC; Schwartz JD; Adair JE; Kiem HP
J Gene Med; 2018 Oct; 20(10-11):e3050. PubMed ID: 30129972
[TBL] [Abstract][Full Text] [Related]
17. Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia.
Oppezzo A; Bourseguin J; Renaud E; Pawlikowska P; Rosselli F
J Clin Invest; 2020 Mar; 130(3):1377-1391. PubMed ID: 31877112
[TBL] [Abstract][Full Text] [Related]
18. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
[TBL] [Abstract][Full Text] [Related]
19. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.
Río P; Segovia JC; Hanenberg H; Casado JA; Martínez J; Göttsche K; Cheng NC; Van de Vrugt HJ; Arwert F; Joenje H; Bueren JA
Blood; 2002 Sep; 100(6):2032-9. PubMed ID: 12200363
[TBL] [Abstract][Full Text] [Related]
20. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.
Dietz AC; Savage SA; Vlachos A; Mehta PA; Bresters D; Tolar J; Bonfim C; Dalle JH; de la Fuente J; Skinner R; Boulad F; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1422-1428. PubMed ID: 28533057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
